Category Archives: Robotics

How efficient your workforce is and how quick they learn and adapt, makes them resilient to face the impact of change

By Kiran N. Kumar

In a peer-reviewed publication, a team from the University of Pittsburgh found that the German workers were not taking to substance abuse as theirAmerican counterparts after robots replaced them in the work environment.

While automation truly enhances productivity and reduces accidents, it was found more harmful to the mental health of human co-workers, suggests the study published last week in Labor Economics from Pitt economist Osea Giuntella.

Read: Robots to wipe out more than half of jobs within next 30 years (June 6, 2016)

Rania Giuntella, co-author of the study from Kenneth P. Dietrich School of Arts and Sciences says, On one hand, robots could take some of the most strenuous, physically intensive, and risky tasks.

On the other hand, the competition with robots may increase the pressure on workers who may lose their jobs or be forced to retrain. Of course, labor market institutions may play an important role, particularly in a transition phase.

Crucial transition phase

These findings reiterate the need for a transition process before robots or Artificial Intelligence (AI) take over most of the jobs, making humans redundant and resilient in work places.

In the US, more people working alongside robots had resulted in a significant increase of 37.8 cases per 100,000 people in drug or alcohol related deaths, besides a slight increase in suicide rate and mental health issues.

When researchers investigated the effects of robotics on workers in Germany, they did not find significant mental-health change due to robotics.

So, the imminent question follows: Why does American automation at work seem to result in much more negative outcomes than in Germany?

Robot exposure did not cause disruptive job losses as Germany has a much higher employment protection legislation, Giuntella explains.

Read: Good bots vs bad bots: In elections, who decides what? (June 22, 2022)

Our evidence finds that, in both contexts, robots have a positive impact on the physical health of workers by reducing injuries and work-related disabilities.

However, our findings suggest that, in contexts where workers were less protected, competition with robots was associated with a rise in mental health problems.

Giuntella, who has studied the effects of robotics on economic stature and marital lifestyle, however, offers no quick-fix solution.

There has been an intense debate on the effects of robotics and automation on labor market outcomes, but we still know little about how these structural economic changes are reshaping key life-course choices, he said.

Choice after job loss

Last year, McKinsey Global Institute predicted that 45 million Americans or one-quarter of the workforce would lose their jobs to automation by 2030, accentuated by Covid-19 pandemic and the possibility of recession.

But optimists argue that automation being constant, loss of jobs remain a temporary phase since new inventions create new markets and new jobs. The opponents point out that the robot job apocalypse scenario due to AI is advancing so quickly that replacement jobs wont keep pace.

Another McKinsey report estimates that the loss of jobs could be 27%, but after diversifying the workforce into new roles, the effective job losses could only be 9%. Still it is high enough not to be discarded easily.

Here, the solution shown should not be isolated to mental impact on the labor force but in German resilience that could be gleaned from the study.

The German worker could adapt to change quickly, but his American counterpart did not. Efficiency of Germans being what it is, American workers are seeking a protective shield instead, in the form of a government bailout or income protection.

Read: Robots are driving U.S. workers towards substance abuse, mental illness (June 30, 2022)

No wonder, a solution offered by Andrew Yang, who was a candidate in the 2020 Democratic Party presidential primaries and the 2021 New York City Democratic mayoral primary, becomes contextual here. He proposed that lack of jobs should entail all Americans to a $1,000 monthly government income.

Is it a solution? In a scenario of 100-meter race, an Olympic runner takes 6 to 7 seconds but an ordinary runner takes more than 20 seconds.

Efficiency matters! How efficient your workforce is and how quick they learn and adapt, makes them resilient to face the impact of change, whether from robots or AI. Unless this is addressed, a holistic solution remains far-fetched.

Link:

Why are robots driving US workers to substance abuse, not... - The American Bazaar

This photo provided by Hyundai Robotics Co. shows the companys disinfection robot.

SEOUL, July 1 (Korea Bizwire) Hyundai Robotics Co., the largest industrial robot manufacturer in South Korea, said Thursday it will release an innovative disinfection robot enabling face-to-face disinfection.

The newly-developed robot uses plasma sterilization, a method that has been used for the sterilization of surgical instruments at hospitals, to sterilize the air, while carrying out floor sterilization using ultraviolet-C (UV-C) LEDs installed on its underside that enable face-to-face disinfection.

The existing disinfection robots in the market typically spray disinfectants that are harmful to humans, while being limited only to non-face-to-face disinfection since UV-C lamps causing skin diseases are installed on the front.

Hyundai Robotics disinfection robot removes various harmful bacteria through its internal plasma sterilization and emits purified air from a vent at the top.

Mounted with eight different types of sensors, it can sense ultra-fine dust and organic chemical compounds in the air and intake and purify them through three-tiered filters.

The robot can disinfect an area of 152 square meters without moving, and can also operate in a self-driving mode. Accordingly, it can carry out disinfection work in lobbies and hallways of buildings where it is hard to install air purifiers and sterilizers.

Kevin Lee (kevinlee@koreabizwire.com)

Read more:

Hyundai Robotics Rolls Out Face-to-Face Disinfection Robot - The Korea Bizwire

June 29, 2022 | Funding for single-cell sequencing, small molecule drug discovery, neurological biomarkers, and more.

$245M: Debut Fund for Life Sciences Technology

Biospring Partners, a female-founded and led growth equity firm exclusively focused on B2B life sciences technology companies, announced the closing of its debut fund with north of $245 million in capital commitments from pension plans, fund of funds, endowments, foundations, and family offices. Biosprings investments are working to push the healthcare industry forward by enabling new forms of biopharma manufacturing, diagnostic testing, and software applications that are fundamentally changing how diseases are researched, diagnosed, and treated.

$60M: Series D Funding for Drug Discovery Robotics

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, has completed a $60 million Series D financing and launched an AI-powered drug discovery robotics laboratory. Capital raised in the round will further bolster Insilicos financial position and fuel the growth of its advancing pipeline, including its lead program, which is currently in a Phase I study, and the continued development of its Pharma.AI platform. In addition, the proceeds will fund ongoing global expansion and planned strategic initiatives, including a fully robotic biological data factory to complement Insilicos vast curated data assets.

$52M: Funding Round for Precision Immunology Pipeline

Endpoint Health, a therapeutics company dedicated to addressing unmet needs in immune-mediated acute and chronic diseases, announced the close of $52 million in equity and debt financing. Proceeds from the funding round will extend the companys precision-first platform and expand its therapeutic pipeline to include programs for chronic immune-mediated diseases. In addition, proceeds will be used to advance Antithrombin III, the companys first precision therapy, to a Phase II clinical trial for the treatment of sepsis. Sepsis is responsible for one in every five deaths worldwide, yet there are few FDA-approved therapies to treat the condition.

$43M: Series F Funding for Cancer Profiling

Epic Sciences, a privately held diagnostics company, has completed a $43 million first close of its Series F financing. The company will use the capital from this additional round of private investment to advance its multi-omic platform and expand operations in areas such as single-cell sequencing and data analytics infrastructure. DefineMBC, Epic's novel blood-based test for comprehensively characterizing metastatic breast cancer, has been reporting patient results since April 2022. The test's multi-analyte methods have demonstrated impressive sensitivity, specificity, accuracy, and precision.

$40M: Series A Funding for Clinical Sequencing

Watchmaker Genomics, a life sciences company specializing in developing high-stringency applications focused on reading, writing, and editing DNA and RNA, announced that it had secured $40 million in an oversubscribed Series A, bringing total funding to date to $53.5 million. With this Series A round of financing, Watchmaker plans to accelerate investment in its protein engineering platform to deliver a suite of new products that address the demands of clinical sequencing and support emerging applications in single-cell analysis, epigenetics, and cell-free DNA. In addition, the company will expand commercial channels and manufacturing capacity, making these product solutions more broadly accessible to the life science and genomics communities.

$37M: Series C Funding for AI-Enabled Precision Oncology

Proscia, a digital and computational pathology solutions company, has raised $37 million to advance how we understand and treat diseases like cancer. This investment brings Proscia's total funding to $72 million. The financing will enable Proscia to accelerate the adoption of computational pathology, strengthening its market and product leadership. It will also use the capital infusion to scale its commercial operation, broaden its portfolio of computational solutions, build on its DermAI and AI melanoma detection success, and extend digital pathology's first suite of process automation solutions beyond Automated QC.

$36.5M: Venture Fund for Genomics Startups

Illumina and LifeArc, a UK independent medical research charity, joined select U.S. and European investors in participating in Time Boost Capitals 30 million genomics venture fund. Time Boost Capital will provide pound-for-pound match funding to every Illumina Accelerator Cambridge graduate securing between 500,000 and 4 million in new capital from qualified investors within 18 months of acceptance. Since opening in July 2020, Illumina Accelerator Cambridge has launched 13 startups focused on harnessing genomics applications to improve human health, including novel therapeutics, diagnostics, synthetic biology, research tools, and agriculture.

$36M: Award for AI-Powered Viral Study Program

A $36 million award from the Defense Threat Reduction Agency, a part of the Department of Defense, will enable the Wake Forest Institute for Regenerative Medicine (WFIRM) to establish a research and development program to study how a virus will invade and infect humans. The program, Pathogenesis and Toxicity Forecasting Using Multi-Organoid Systems, or PATMOS, uses WFIRMs Body-on-a-Chip platform to investigate the biochemical changes in viral infections. The platform consists of an advanced 3D model of human tissues or organs. The PATMOS program will infect the 3D organs, or organoids, with different viruses and analyze what happens throughout an infection.

$30M: Series A Funding for Small Molecule Drug Discovery

Anagenex, a drug discovery company pairing large-scale data generation with machine learning to discover the next generation of small molecule medicines, announced that it closed a $30 million Series A financing round. Anagenex will use the funds to expand its novel data-generating platform and build a robust pipeline of programs addressing challenging unmet medical needs. The Anagenex platform iteratively assesses up to billions of compounds in parallel to generate extraordinarily high-quality data. Armed with these enormous datasets and highly accurate models, Anagenex has the tools to address some of the most challenging targets in drug discovery.

$27M: Series B Funding for Heart Disease Diagnostics

Elucid announced closing a $27 Million Series B financing round. The Elucid platform is the only FDA-Cleared and CE-Marked software to quantify plaque morphology validated against tissue specimens objectively. Specifically, the exquisite algorithms developed through machine learning characterize tissue types in the artery wall known to cause heart attacks. The capability to discern complex plaque biology at the cellular and molecular level is powering new applications to derive fractional flow reserve, risk of heart attack/stroke, and expression prediction. This comprehensive approach enables physicians to diagnose the direct cause of chest pain and determine if patients have early-stage heart disease, which alternative methods cannot see.

$25M: Series A Funding for Neurological Diseases

NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, announced $25 million in Series A funding. The round will support the company as it seeks to improve the design of neurological clinical trials, increase the probability of success for novel neurological therapeutics, and usher in a new era of precision medicine for neurology. NeuraLight leverages proprietary computer vision and deep learning algorithms to extract all relevant oculometric markers from facial videos captured with a standard webcam or smartphone. The companys technology applies to various neurological disorders, initially focused on Alzheimers disease, Parkinsons disease, Multiple Sclerosis, and ALS.

$21M: Series A Funding for Early Detection Cancer Test

Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early detection of any cancer, announced the raise of $21 million in a Series A financing round led by Bonnier Ventures. The company will use the capital to develop and validate blood and urine tests for Multi-Cancer Early Detection (MCED) in adults with no cancer symptoms and to detect recurrence in kidney cancer patients. The tests are based on the detailed profiling of human glycosaminoglycansalso known as the GAGomeas biomarkers of cancer metabolism. Detecting stage I cancer is the key challenge here, and whereas other MCED tests based on cell-free DNA struggle to find cancer at this early stage, metabolism-based biomarkers could make a difference.

$19M: Series A Funding for Gastrointestinal Diagnostics

Gemelli Biotech, a company focused on improving health by providing precision diagnostics for gastrointestinal diseases, announced the completion of a $19 million Series A financing. Gemelli will use the capital to accelerate the commercialization of its trio-smart and ibs-smart precision diagnostic tests, including expanding sales and marketing across the US and the scale-up of laboratory and manufacturing capacity. Gemelli has launched two products: trio-smartthe only clinical breath test that measures levels of hydrogen, methane, and hydrogen sulfide to provide clinicians and patients with a complete picture of gut healthand ibs-smarta patented diagnostic blood test for post-infectious irritable bowel syndrome.

$10M: Funding for Immunotherapy Research

The Mark Foundation for Cancer Research and the Bloomberg~Kimmel Institute for Cancer Immunotherapy announced a new $10 million commitment to Johns Hopkins University. This investment allows for novel work, advanced immunotherapy research, and lifesaving breakthroughs for cancer patients. The Mark Foundation Centers fundamental research priorities include studying how cancer evades the immune system and spreads. Of the $10 million investment, The Mark Foundation is donating $6 million, and BKI is providing $4 million, helping scientific teams to continue using innovative technologies to determine why certain patients do not respond to immunotherapies.

$9M: Research Grant for Lung Cancer Technology

The Perelman School of Medicine at the University of Pennsylvania received a five-year, $9 million research grant from the National Cancer Institute for imaging technology that illuminates lung tumor tissue, helping clinicians detect and remove it. This technology, intraoperative molecular imaging (IMI), is based on fluorescent beacon molecules that target and bind themselves to tumor cells, essentially making them glow, allowing doctors to distinguish cancer from healthy tissue easily. Penn researchers with the Center for Precision Surgery in the Abramson Cancer Center and colleagues at other institutions will use the research grant to study and improve IMI technology for non-small-cell lung cancers.

$2.9M: Funding for Tumor Antibody Drug Conjugates

Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, announced that it secured funding of 2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs to treat solid tumors. Spireas technology allows for a higher drug-to-antibody ratio, which means more drugs reach the cancer cell for the development of stable and tailored ADCs incorporating a variety of drug payloads at varying potency levels and different modes of action. This method will result in significantly better efficacy and safety profiles for cancer therapeutics.

Undisclosed Funding for Drug Discovery Technology

Optibrium, a drug discovery software developer, announced it had secured further investment from existing investors Kester Capitala UK mid-market private equity firmto develop and commercialize its computer-aided drug discovery technologies, make future appointments to the senior leadership team, and continue expansion across Europe and the United States. Optibriums products enable preclinical drug discovery, focusing on hit to lead and lead optimization phases extracting maximum value from pharmaceutical data to target high-quality compounds and accelerate discovery cycles confidently.

Continue reading here:

Follow the Money: Drug Discovery Robotics Lab, Clinical Sequencing Platform, More - Bio-IT World

The Delhi Board of School Education (DBSE) has roped in experts from IIT Delhi to design the robotics and automation curriculum for the city government's Schools of Specialised Excellence (SoSE), according to officials.

Through this curriculum, students will be trained in different aspects of robotics and automation which will enable them to pursue higher education and diverse careers pathways in the field, they said. "It is important that schools now start offering courses beyond the regular subjects.

The future will appreciate individuals with adept skill set in areas of new generation technologies like robotics, automation, machine learning and artificial intelligence, which is going to be the norm of functioning for every industry in the near future," Himanshu Gupta, Education Director, said. "With this in mind, the SoSE has put IIT Delhi's Technology Innovation Hub and I-Hub Foundation for Cobotics (IHFC) in charge of designing the syllabus, which will be more progressive and industry-relevant in terms of robotics and automation including but not limited to mechanics, electronics, robotics programming, IoT etc.

The whole idea is to curate teaching material and content for ease of learning," he said. Gupta explained that the IHFC will collaborate with industry partners and players to create an industry-relevant curriculum that will render SoSE students employable in aspirational job roles after four years of specialised study in the domain of robotics and automation.

IHFC will also extend support by lending the expertise of industry partners, academia partners and the alumni in designing experiential learning opportunities for students such as internship, apprenticeship, guest lectures, masterclasses, visits and projects, which will contribute to an immersive and hands-on learning.

Go here to read the rest:

IIT Delhi plans for robotics and automation - The Hans India

Mentions of robotics within the filings of companies in the automotive industry fell 32% between the final quarter of 2021 and the first quarter of 2022.

In total, the frequency of sentences related to robotics between April 2021 and March 2022 was 60% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.

!function(){use strict;window.addEventListener(message,(function(e){if(void 0!==e.data[datawrapper-height]){var t=document.querySelectorAll(iframe);for(var a in e.data[datawrapper-height])for(var r=0;r

When companies in the automotive industry publish annual and quarterly reports, ESG reports and other filings, GlobalData analyses the text and identifies individual sentences that relate to disruptive forces facing companies in the coming years. Robotics is one of these topics companies that excel and invest in these areas are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges.

To assess whether robotics is featuring more in the summaries and strategies of companies in the automotive industry, two measures were calculated. Firstly, we looked at the percentage of companies which have mentioned robotics at least once in filings during the past twelve months this was 51% compared to 33% in 2016. Secondly, we calculated the percentage of total analysed sentences that referred to robotics.

Of the 10 biggest employers in the automotive industry, Denso was the company which referred to robotics the most between April 2021 and March 2022. GlobalData identified 10 robotics-related sentences in the Japan-based companys filings 0.3% of all sentences. Mercedes-Benz mentioned robotics the second most the issue was referred to in 0.13% of sentences in the companys filings. Other top employers with high robotics mentions included Stellantis, Magna and BYD.

Across all companies in the automotive industry the filing published in the first quarter of 2022 which exhibited the greatest focus on robotics came from Schaeffler. Of the documents 2,919 sentences, 13 (0.4%) referred to robotics.

This analysis provides an approximate indication of which companies are focusing on robotics and how important the issue is considered within the automotive industry, but it also has limitations and should be interpreted carefully. For example, a company mentioning robotics more regularly is not necessarily proof that they are utilising new techniques or prioritising the issue, nor does it indicate whether the companys ventures into robotics have been successes or failures.

In the last quarter, companies in the automotive industry based in Asia were most likely to mention robotics with 0.13% of sentences in company filings referring to the issue. In contrast, companies with their headquarters in the United States mentioned robotics in just 0.04% of sentences.

!function(){use strict;window.addEventListener(message,(function(e){if(void 0!==e.data[datawrapper-height]){var t=document.querySelectorAll(iframe);for(var a in e.data[datawrapper-height])for(var r=0;r

Here is the original post:

Filings buzz in the automotive industry: 32% decrease in robotics mentions in Q1 of 2022 - just-auto.com

In a recent call with a customer, I was told they were looking to build a new facility and investigating installing a tow-line to index our build carts down the assembly line. The company really liked the flexibility and scalability of an automated guide vehicles (AGV) or autonomous mobile robots (AMR), but they believed a tow line may have a higher ROI.

On the surface, this customers initial inclinations seemed plausible. The assembly line under evaluation was 20 build stations, with moving build carts that were designed for up to 4000 lbs each. As we dug into the application, however, we quickly realized that it was not necessarily true that tow lines are vastly more cost efficient than AGVs. The same holds for AMRs, but given the weight of the product in this assembly line, an AMR solution was not appropriate.

Two ConsiderationsThe analysis began with a review of the processs takt time, that is, the time needed to complete a product to meet customer demand. The customers process was set to 46 minutes. We also examined how much time is allocated to each workstation before the line must index forward.

When assessing a process with long takt times for AGV vs tow line conveyance, there are two key considerations:

Build Carts and AGVsWith more time in station, AGVs have more time to move between stations. It is therefore critical to understand if the AGV must be dedicated to each build cart or if the carts and AGVs can be separate entities.

In many instances, there is no technical need for the AGV to be permanently connected to its companion frame cart that sits on top of it. In these scenarios, tunneling AGVs are a feasible solution that can lead to cost savings. This simulation highlights how only a small number of AGVs can be used to index an entire assembly line.

As the name implies, a tunneling AGV is a vehicle that tunnels underneath a build cart and engages via a pin mechanism. While the pin is engaged, the cart is coupled to the AGV and moves to where the AGV takes it. Once the AGV positions the carts in their next stop, the AGV disengages and is free to go move something else.

Read more:

AGVs & AMRs as Alternatives to Tow Line Conveyance - Robotics Business Review

NEW YORK, June 30, 2022 /PRNewswire/ -- The global Crop Harvesting Robots Marketsize is expected to grow by USD 1455.57billion at a CAGR of 28.36% as per Technavio. Thereport extensively coverscrop harvesting robots marketsegmentation by product (fruit and vegetable harvesting robots and grain harvesting robots) and geography (North America, Europe, APAC, South America, and MEA).

Read the 120-page report with TOC on "Crop Harvesting Robots Market Analysis Report byProduct (Fruit and vegetable harvesting robots and Grain harvesting robots) and Geography (North America, Europe, APAC, South America, and MEA), and the Segment Forecasts".Buy the Sample Report Now!

The market is driven by the increasing focus on farm mechanization. In addition, the growing popularity of solar-powered crop harvesting robots is anticipated to boost the growth of the crop harvesting robots market.

Machines are steadily replacing people in agriculture in various countries and have significantly reshaped the agricultural landscape. The productivity of the farm has a direct relationship with the efficient utilization of farm implements. Crop harvesting robots have been gaining popularity as an effective solution for harvesting across farms, greenhouses, and nurseries. They have widely been used as an effective solution for labor shortage problems during the harvesting season in various countries.

Some of the crop harvesting robots commonly used are lettuce harvesters, cucumber harvesters, wheat harvesters, barley harvesters, and sweet pepper harvesters. Thus, the increasing focus on farm mechanization will drive the demand for crop harvesting, thereby driving market growth.

Download Sample:for more additional information about the Crop Harvesting Robots Market

Major Five Crop Harvesting Robots Companies:

For the Right Perspective & Competitive Insights.Make confident decisions using our benchmarks and analysis.Get Sample Report

Crop Harvesting Robots Product Outlook (Revenue, USD mn, 2021-2025)

Crop Harvesting Robots Regional Outlook (Revenue, USD mn, 2021-2025)

Are you a start-up willing to make it big in the business? Grab an exclusive Report

Related Reports

Vertical Farming Technologies Market by Application and Geography - Forecast and Analysis 2022-2026

Precision Agriculture Market by Product and Geography - Forecast and Analysis 2022-2026

Crop Harvesting Robots Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 28.36%

Market growth 2021-2025

$ 1455.57 billion

Market structure

Fragmented

YoY growth (%)

26.16

Regional analysis

North America, Europe, APAC, South America, and MEA

Performing market contribution

North America at 39%

Key consumer countries

US, Germany, UK, China, and France

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agrobot, Cerescon BV, Clearpath Robotics Inc., Dogtooth Technologies Ltd., Energid Technologies Corp., FFRobotics, Green Robot Machinery Pvt. Ltd., Harvest Automation, Harvest CROO Robotics, and Torguga Agricultural Technologies Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/global-crop-harvesting-robots-market-increasing-focus-on-farm-mechanization-to-boost-market-growth-evolving-opportunities-with-abundant-robotics-inc-and-agrobot--technavio-301577776.html

SOURCE Technavio

Read more here:

Global Crop Harvesting Robots Market| Increasing focus on farm mechanization to boost market growth| Evolving Opportunities with Abundant Robotics...

As a family of robots, the IRB 1200 comes in two variants which can handle a wide range of applications. Both IRB 1200 variants can be mounted at any angle and come with IP 40 protection as standard. Both variants are available with Food Grade Lubrication, SafeMove, Foundry Plus 2 and Clean Room option. The 700 mm reach variant can carry a payload of up to 7 kg, while the longer reach 900 mm variant can carry up to 5 kg of payload.

Food Grade Lubrication and Clean Room optionThis Food Grade Lubrication (NSF H1) option includes Clean Room ISO class 3 and IP67 protection rating which ensure uncompromising safety and hygiene for food and beverage applications. The Clean Room ISO class 3 design eliminates the potential for contamination of the food handling area. This option provides smooth surfaces and makes it easy to keep clean and maintain in environments such as CNC machine tending and material handling in the food industry. This results in features that allow for 15% smaller cells with 10% shorter cycle times.

CompactThe IRB 1200 has no offset in axis two, which results in a longer stroke than other small robots and it, meaning it can be placed very close to the work piece and still be functional.

Go here to see the original:

IRB 1200 | ABB Robotics - Industrial Robots Portfolio | ABB Robotics

SafeMove, ABBs safety solution, provides greater flexibility, space savings, and cutting edge commissioning tools for higher productivity at a lower total cost of investment. All this, combined with unsurpassed safety, enables closer collaboration between robots and factory workers while reducing total investment by up to 30%.

First introduced in 2008, SafeMove performs safety certified monitoring of robot motion, tool and standstill supervision as well as speed limitation.

Working hand-in-hand with our customers to develop innovative robot safety technologies, ABB introduces SafeMove. It allows for the creation of more efficient and flexible production scenarios, and integrates safety fieldbus connectivity into ABBs IRC5 robot controller family.

Supported robots and controllers - Able to support all robot mounting angles, SafeMove is available for use with the majority of ABBs robot and controllers.

Collaboration - With SafeMove the tools to facilitate collaboration between man and machine are a reality.

RobotStudio - Safety configurations are now faster and more efficient. Taking full advantage of our premier offline programming tool, RobotStudio.

Faster commissioning times - SafeMove includes a set of easy-to-use tools for fast setup, validation and commissioning.

See the original post here:

SafeMove - Industrial Robot Controllers | ABB Robotics

Robotics is the overlapping of the computer science and engineering fields. Its dedicated to the designing, manufacturing, and use of autonomous, semi-autonomous, and non-autonomous robots.

The study of the field aims to create machines that are intelligent and dexterous, allowing them to assist humans in a wide variety of scenarios, from scientific experimentation and medical to life-threatening circumstances.

See below to learn all about the global robotics market:

The global service robotics market was estimated at $34.4 billion in 2020. Its expected to maintain a Compound Annual Growth Rate (CAGR) of 21.2% over the forecast period from 2020 to 2026, reaching $110.4 billion by the end of it.

By type, the hardware segment of the global market is projected to have a CAGR of 20.7% over the analysis period, while the software segment is forecast to have a 22.8% CAGR over the same analysis period.

Regionally, the global robotics market is segmented as follows:

By industry vertical, the health care industry is one of the leading users of robotics in the global market.

Other notable industry verticals include:

Robots have been around for decades in factories and warehouses in their most rudimentary form as automated machines. With the growth of hardware and software advancements in the field of robotics, estimates suggest a total count of 20 million robots by 2030.

Similarly, a McKinsey report estimates a decline of 18% in physical and manual labor and 28% in basic cognitive skills-based labor by 2030, which could make room for more jobs with expertise in STEM and socioemotional skills, in addition to major advances in health care and defense technology.

The rapid rise of robots means that were witnessing a major shift in the types of jobs that make up our workforce while many jobs and job roles are being eliminated, new ones are being created, and the vast majority of them are designed to improve AI or to use the results of AI (i.e., perform judgment), says Toby McClean, member of the Forbes Technology Council.

These new jobs will focus on more complex problems requiring higher-level critical thinking and analytical skills, and they will be needed across industries.

The field of robotics is vast and can be categorized in numerous ways depending on specific features. Most commonly, robots are categorized by their autonomy levels and the tasks theyre capable of performing

Autonomous robots are capable of acting and performing tasks without needing human control or supervision. While not strictly necessary, autonomous robots are becoming increasingly more dependent on artificial intelligence (AI) to navigate their surroundings independently.

Semi-autonomous robots are less independent than their fully autonomous counterparts. Capable of making decisions and performing actions on their own, they need real-time directions in some situations.

Non-autonomous robots are all robots that require external intervention to operate. This includes remote-controlled robots that must receive directions in real-time from a human in order to act.

When divided into more task-specific categories, robots can be found in a variety of categories, such as:

Articulated robots, or robotic arms, are robots with rotary joints meant to emulate the human arm, usually on a bigger scale. They contain anywhere from two to 10 rotary joints, with varying degrees of motion and dexterity.

While they tend to overlap in function and ability with other types, humanoid robots are distinctly recognizable with their human-like forms. Their capabilities, levels of intelligence, and autonomy depend on their functional purpose and whether its meant to interact with people in an environment or its simply for research purposes.

Collaborative robots, or cobots, are designed to function alongside humans. Cobots are capable of safely working in environments shared with humans, allowing them to increase productivity. Theyre also used in minimizing the risks of manual and dangerous tasks.

Soft robots are one of the latest robotics inventions that replace solid materials with soft alternatives. These use pressurized gas or liquid to maintain their shape and move around. They vary in their degree of autonomy, but are more flexible than the average robot, making them ideal for handling delicate objects or accessing narrow spaces.

Robotics continues to be one of the most revolutionary inventions, due to their contribution to a wide variety of fields, ranging from medicine and health care to manufacturing and high-risk work.

Some notable benefits of robotics include:

Robotics solutions tend to be customizable to meet the specific demands of the business or manufacturer it serves:

Amazon Robotics, formerly known as Kiva Systems, is a software developer and manufacturer of machinery used in Amazons warehouses and fulfillment centers. Based in Massachusetts, its main product is mobile robotic order fulfillment systems.

Switching from a manual item scanning model to machine learning (ML), Amazon Robotics stayed under the same brand name. Working with AWS, it used Amazon SageMaker to help its developers prepare, build, train, and deploy their ML models on the fulfillment robots.

Amazon SageMaker doesnt just manage the hosts we use for inferencing. It also automatically adds or removes hosts as needed to support the workload, says Eli Gallaudet, senior software manager, Amazon Robotics.

Amazon SageMaker doesnt just manage the hosts we use for inferencing. It also automatically adds or removes hosts as needed to support the workload.

Amazon Robotics was able to save 50% on inferencing costs, improve computer performances by 40%, and was able to save 20% on its computing costs.

Alliora is a cardboard box manufacturer based in northwestern France. It produces a wide variety of boxes for clients in a range of markets, such as cosmetics, board games, and champagne.

Alliora attempted to introduce automation to the production line with an industrial robot that was difficult to use. However, the need for automation was still important, as the repetitive tasks led some employees to develop musculoskeletal disorders.

Contacting one of its local robotics distributors, Sterkelec, Alliora ended up using the Robotiq Palletizing Solution, which consists of a collaborative robot arm and a vacuum-powered end-effector.

I am not a roboticist. Im not an automatician. But Davy Pourrieau [Sterkelecs product manager] explained it to me right away, and within 45 minutes, I understood how the system worked, says ric Bleau, production director, Alliora.

Using a cobot on one of its production lines, Alliora was able to hire two fewer workers during its high production periods and achieve an overall smoother production line.

Kidd Creek Mine is an underground metal mine located in Ontario, Canada. Owned and run by Glencore, a Swiss multinational company, the mines operations are supported by numerous unmanned aerial services as well as underground inspection specialists.

The workers at the Kidd Creek Mine are used to traditional tools in their work and inspections. They also used basic robots to access prospective mining areas to ensure the safety of the miners.

Working with Boston Dynamics and its four-legged robot, Spot, they had access to more accurate data. The automated robot withstands an array of harsh terrain with no problem.

Having a tool that can quickly, reliably get into everywhere that we need to get information and bring it back to us is invaluable to our business, says Iain McKillip, manager of mine technical services, Kidd Operations.

As engineering-driven mining relies primarily on up-to-date data, Boston Dynamics has enabled Kidd Creek to obtain a continuous stream of data to make decisions concerning worker safety.

Some of the leading providers of robotics solutions and innovations in the in the. market include:

Excerpt from:

The Robotics Market in 2022 - Datamation